trihexyphenidyl hydrochloride tablet
actavis pharma, inc. - trihexyphenidyl hydrochloride (unii: ao61g82577) (trihexyphenidyl - unii:6rc5v8b7po) - trihexyphenidyl hydrochloride 2 mg - this drug is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). it is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.
gavilyte-h and bisacodyl- polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl delaye
lupin pharmaceuticals, inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - bisacodyl 5 mg - gavilyte - h and bisacodyl delayed-release tablet, usp is indicated for cleansing of the colon as a preparation for colonoscopy in adults. the gavilyte - h and bisacodyl delayed-release tablet, usp is contraindicated in the following conditions: - gastrointestinal (gi) obstruction - bowel perforation - toxic colitis and toxic megacolon - gastric retention - ileus pregnancy category c animal reproduction studies have not been conducted. it is not known whether gavilyte - h and bisacodyl delayed-release tablet, usp can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. gavilyte - h and bisacodyl delayed-release tablet, usp should be given to a pregnant or nursing woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when gavilyte - h and bisacodyl delayed-release tablet, usp is administered to a nursing woman. safety and effectiveness in pediatric patients has
trihexyphenidyl 2mg tablets
crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - trihexyphenidyl hydrochloride - tablet - trihexyphenidyl hydrochloride 2 mg - anti-parkinson drugs
trihexyphenidyl 5mg tablets
crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - trihexyphenidyl hydrochloride - tablet - trihexyphenidyl hydrochloride 5 mg - anti-parkinson drugs
trihexyphenidyl hydrochloride tablet
clinical solutions wholesale, llc - trihexyphenidyl hydrochloride (unii: ao61g82577) (trihexyphenidyl - unii:6rc5v8b7po) - trihexyphenidyl hydrochloride 2 mg
trihexyphenidyl hydrochloride tablet
remedyrepack inc. - trihexyphenidyl hydrochloride (unii: ao61g82577) (trihexyphenidyl - unii:6rc5v8b7po) - trihexyphenidyl hydrochloride 2 mg
trihexyphenidyl hydrochloride tablet
avera mckennan hospital - trihexyphenidyl hydrochloride (unii: ao61g82577) (trihexyphenidyl - unii:6rc5v8b7po) - trihexyphenidyl hydrochloride 2 mg
bisacodyl- bisacodyl enteric coated tablet, coated
ncs healthcare of ky, inc dba vangard labs - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 5 mg - stimulant laxative -relieves occasional constipation and irregularity -this product generally produces bowel movement in 6 to 12 hours
bisacodyl laxative- bisacodyl suppository
medicine shoppe international inc - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 10 mg - stimulant laxative - for relief of occasional constipation - this product generally produces bowel movement in 15 minutes to 1 hour
bisacodyl suppository
h and p industries, inc. dba triad group - bisacodyl (unii: 10x0709y6i) (bisacodyl - unii:10x0709y6i) - bisacodyl 10 mg - stimulant laxative - for relief of occasional constipation - this product generally produces bowel movement in 15 minutes to 1 hour